Abetan, Sabat E.

HRN: 28-68-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/09/2026
03/16/2026
IV
600mg
Q8h
Mass Left Thigh Prob Malignant
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: